Slingshot members are tracking this event:
Regeneron (REGN) and Sanofi (SNY) Announce Phase 3 SARIL-RA-MONARCH Results Evaluating Sarilumab Compared to AbbVie's (ABBV) Humira in Rheumatoid Arthritis (RA)
Slingshot Insights Explained
Nov 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Saril-ra-monarch, Sarilumab, Humira, Rheumatoid Arthritis, Adult Patients